|
Laurie Arrants
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Debra Babcock, M.D., Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Laurel Beckett, Ph.D.
UC Davis
Working Group: Discovery/Exploratory Science
Ken J. Bergmann, M.D., FAAN
U.S. Food and Drug Administration
Working Group: Clinical
David Brooks, M.D., D.Sc.
Imperial College
Working Group: Clinical
Andrea Brucin, Ph.D.
Foundation for the National Institutes of Health
Lucie Bruijn, Ph.D.
ALS Association
Neil Buckholtz, Ph.D.
National Institute on Aging
National Institutes of Health
Working Group: Clinical
Cindy Casaceli
University of Rochester
Jesse Cedarbaum, M.D.
Cytokinetics, Inc.
Christopher Coffey, Ph.D.
University of Iowa
Thomas Comery
Pfizer, Inc.
Working Group: Clinical
Amy Comstock Rick, J.D.
Parkinson's Action Network (PAN)
Working Group: Clinical
Roderick A. Corriveau, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Merit Cudkowicz, M.D.
Harvard
Alison Drone
Foundation for the National Institutes of Health
Karen L. Edwards, Ph.D.
University of Washington
Marian Emr
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Greg Farber, Ph.D.
National Institute of Mental Health
National Institutes of Health
Mats Ferm
Astra Zeneca
Working Group: Discovery/Exploratory Science
Bob Finkelstein, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Wendy Galpern, M.D., Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Katrina Gwinn, M.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Mark Hallett, M.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Working Group: Clinical
Franz Hefti, Ph.D.
Acumen Pharmaceuticals, Inc.
Working Group: Discovery/Exploratory Science
Lynn D. Hudson, Ph.D.
Critical Path Institute
Andreas Jeromin, Ph.D.
Banyan Biomarkers, Inc.
Working Group: Clinical
Walter Koroshetz, M.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Rainer Kuhn, Ph.D.
Novartis
Working Group: Discovery/Exploratory Science
Story Landis, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health
|
Chi-Ming Lee, Ph.D.
Astra Zeneca
Ernie Lyons, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Robert Martone
Covance Biomarker Center of Excellence
Working Group: Discovery/Exploratory Science (Chair)
Darius Matusevicius, M.D., Ph.D.
Astra Zeneca
Working Group: Clinical
Matthew McAuliffe, Ph.D.
Center for Information Technology
National Institutes of Health
Elizabeth McNeil, M.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Jane Paulsen, Ph.D.
University of Iowa
Working Group: Clinical
Joel Perlmutter, M.D.
Washington University in St. Louis
Working Group: Discovery/Exploratory Science
Ron Petersen, M.D., Ph.D.
Mayo Clinic College of Medicine
Shanta Rajaram, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bernard Ravina, M.D., M.S.
Biogen
Working Group: Clinical
Ian Reynolds, Ph.D.
Henry Rodriguez, Ph.D., M.B.A.
National Cancer Institute
National Institutes of Health
Working Group: Clinical
Gary Romano, M.D., Ph.D.
Janssen Pharmaceuticals
Working Group: Clinical
Yaffa Rubinstein, Ph.D.
National Center for Advancing Translational Sciences
National Institutes of Health
Kathleen Shannon, M.D.
Rush University Medical Center
Working Group: Discovery/Exploratory Science
Todd Sherer, Ph.D.
Michael J. Fox Foundation for Parkinson's Research
Working Group: Discovery/Exploratory Science
Beth-Anne Sieber, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health
John Sims, M.D.
Eli Lilly
Working Group: Clinical
Holly Soares
Bristol Myers Squibb
Working Group: Clinical
Coryse St. Hillaire-Clarke, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health
David Standaert, M.D., Ph.D.
University of Alabama at Birmingham
Working Group: Clinical (Chair)
Margaret Sutherland, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Anna Taylor, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Barbara Tilley, Ph.D.
University of Texas
Working Group: Clinical
Christine L. Torborg, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Dave Weiner, M.D.
Working Group: Discovery/Exploratory Science
Alan L. Willard, Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Janet Woodcock, M.D.
U.S. Food and Drug Administration
Working Group: Clinical
|
Parkinson's Disease
